beta

Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging

Thu Apr 10 2025

Recall Summary

This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.

    Affected Products

    Product NameNumber of Affected Units
    Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packsAbout 14,250

    Remedies

    Remedy
    Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.

    Hazards

    HazardType of Hazard
    The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.Not specified

    Injuries

    Injury
    None reported

    Manufacturers

    Info not provided.

    Retailers

    Retailer
    HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
Comments (-)

Must be signed in to post a comment.

No comments.

Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging - Late Recalls